Ralph Benatar

Ralph Benatar, Chemist, MBA, has worked in the high-tech industry for over 35 years. He has held senior positions within several organizations.

Founder and Co-President, OtolaneSoft Corporation.
Otolane is a virtual platform developed according to latest-generation technological standards to meet the growing needs of the automotive industry.

President, Exchange Market Systems – EMS.
EMS was the first digital platform to offer Web-based financial and stock market information to the majority of banks in Canada. Its clients include TD Greenline, E-trade, HSBC, TD Waterhouse, Hong Kong Bank, CIBC, and the National Bank. The company was acquired by Sungard, the largest Financial Services institution in the United States.

Co-President, Virtual Age International, uMind.
Virtual Age International, uMind is an internationally recognized kingpin in the field of e-learning. Its clients include Hydro-Québec, the Government of Alberta, Nova Bus, Novo Nordisk, STM, and McGill University.

Head of Operations and Chief Financial Officer, NHC Communications.
NHC Communications, listed on the Toronto Stock Exchange with a market capitalization of $400M, specializes in electronic switches for telecommunication companies. Its customers include Verizon, Bell South, and France Télécom.

Shareholder and Board Member, MuxLab.
For more than 35 years, MUXLAB has been a leader in designing and producing closed-circuit audio, video, and television connectivity solutions.

Shareholder and Board Member, US Debt Ventures.
Having developed its own algorithms for risk assessment and management, USDV specializes in acquiring scores and mortgages from banking institutions.

Read more
Olivier Beauchet
Research & Development Advisor

Dr. Olivier Beauchet is a full professor at the Faculty of Medicine of the University of Montreal and an assistant professor in the Department of Medicine at McGill University (Montreal, Quebec, Canada).

As a geriatrician and a neurologist in the Departments of Medicine and of Geriatrics, he practices at the Institut Universitaire de Gériatrie de Montréal (IUGM).

As a clinician-scientist, Dr. Beauchet directs the "Vulnerability and Longevity" clinical research laboratory at the research institute of the IUGM. He is also a Senior Researcher at the Lady Davis Institute for Medical Research at the Jewish General Hospital.

He has more than 334 international publications in peer-reviewed scientific journals, of which 20 articles have been cited more than 200 times, positioning him as an international expert on aging of more than 20 years’ experience. He is also recognized worldwide for his ability to initiate, structure, and disseminate innovative clinical research that gives rise to concrete improvements to the health, autonomy, and quality of life of older adults.

A specialist in standardized geriatric assessments and the action-research approach, Dr. Olivier Beauchet practices pragmatic science in service of older adults, whom he invites to reinvest the path to successful aging while being positioned at the heart of the solution development process.

As early as 2011, Dr. Beauchet became interested in telehealth that is designed for and by older adults, creating solutions based on the self-assessment approach. Early on, this insight also proved to be an opportunity to couple telehealth solutions with artificial intelligence and innovative interventions. Among other successes, this resulted in neural network-based decision-making algorithms that have surpassed all existing models for predicting recurrent falls in the elderly.

Acting as an expert within the Quebec Ministry of Health and Social Services during the first wave of the COVID-19 pandemic, Dr. Olivier Beauchet created, validated, and deployed a clinical socio-geriatric assessment tool for homebound older adults called ESOGER. Recognized by the Quebec Ministry of Health and Social Services and supported by the Guedj Report to the French Ministry of Solidarity and Health, this tool is now considered a service of reference within the Support for the Autonomy of the Elderly (SAPA) program of Quebec’s CISSSs and CIUSSSs. Thanks to funding from the Fonds de recherche du Québec en santé, Dr. Beauchet is continuing to pursue research on ESOGER with the aim of improving the tool and increasing its effectiveness.

The solutions developed by iTeQ Telehealth draw directly from Dr. Olivier Beauchet's research and expertise, which allows us to offer older adults, their caregivers, and the professionals who care for them the most appropriate solutions to achieve healthy aging, a good quality of life, and social inclusion in a way that is adapted to their expectations.

Read more
Guillaume Collard
CTO - Chief Technology Officer

Guillaume Collard created his first website at the Web’s beginnings, aged 12. At 15, he developed artificial intelligence for a video game.

During his studies in cognitive science, neuropsychology, and sociology, Guillaume was twice declared the winner of a university computer science competition, inciting him to develop Code Lion, a Web agency specialized in the development of complex medical applications.

As the co-founder of the research and development laboratory Sentimens, Guillaume has cultivated expertise in designing and developing innovative technological solutions that combine big data and artificial intelligence.

Through his partnership with the McGill RUISSS Centre of Excellence on Longevity and the research institute of the IUGM’s laboratory, he acts as the technological lead, contributing to the technical development of the CARE and ESOGER solutions alongside Dr. Olivier Beauchet and Kévin Galéry.

Read more
Kévin Galéry
Research & Development Advisor

A scientist and gerontologist by training, Kévin Galéry has 15 years of experience managing research projects, including 7 years as project director at the Gérontopôle Autonomie et Longévité, a French aging research centre.

After relocating to Quebec in 2018, Kévin served as Deputy Scientific Director of the McGill RUISSS Centre of Excellence on Longevity for 3 years, after which he became Deputy Director of the "Vulnerability & Longevity" research laboratory at the research institute of the IUGM.

Since 2011, Kévin has been working with Dr. Beauchet and Guillaume Collard to develop telehealth self-assessment solutions for older adults. He participated in the creation and scientific validation of several assessment tools, including the Brief Geriatric Assessment, CESAM, and ESOGER.

Read more
Cyrille Launay
Research & Development Advisor

Dr. Cyrille Launay is an assistant professor and researcher-clinician in the geriatric department at the Jewish General Hospital.

In 2011, he was appointed to the positions of University Clinical Director and Chief Resident in the department of Internal Medicine and Gerontology at the CHU hospital in Angers, France.

In 2015, Dr. Launay joined the division of geriatric medicine at the Université de Lausanne as Clinical Director.

His passion for teaching led him to develop a geriatric e-learning platform, as well as to teach geriatrics to post-graduate students in the rehabilitation department at the CHUV Lausanne.

After three years at the geriatric division of the Université de Lausanne, he arrived in Quebec in 2018 as a doctor at the Institut Universitaire Gériatrique de Montréal.

His passion for geriatrics is also evident in his doctorate thesis, the subject of which was the Brief Geriatric Assessment, a tool for predicting prolonged length of stay in hospital. Dr. Launay’s research is concerned with the prediction of undesirable health events in hospitalized senior patients, particularly with regard to emergency services. His principal publications focus on the predictive performance of screening tools, in order to offer the right care to the right patient at the right moment.

Throughout his career, he has participated in a number of national and international conferences, and has to his credit about a hundred published and reviewed scientific works, as well as numerous thesis supervisions. He has also offered many training courses such as “Union Nationale de l'Aide, des soins et des services à domicile” [National Union of aid, care and services at home], France Alzheimer, and “Les géronto-technologies” [Geronto-technology], to name a few.

Dr. Launay is a member of the Association of Young Hospital Geriatricians and co-chair of the Canadian Geriatrics Society interest group “Seniors and Emergencies”. He aims to promote the study of all aspects of ageing, progress for the general well-being of older adults, and the acquisition of clinical knowledge in geriatrics.

Read more
Alain Ptito
Research & Development Advisor

Dr. Alain Ptito is a professor in the Department of Neurology and Neurosurgery at McGill University and a neuropsychologist and senior researcher at the Montreal Neurological Institute and Hospital and the Research Institute of the McGill University Health Centre (MUHC). Until October 2020, he was the director of the Department of Psychology at the MUHC.

Dr. Ptito's research program involves studying the mechanisms underlying brain reorganization and plasticity in hemispherectomized and callosotomized patients, as well as in those with Parkinson's disease or acquired brain injuries, particularly stroke and head trauma. His clinical work includes the neuropsychological assessment of these patients.

Dr. Ptito studied clinical psychology at McGill University (1975) and pursued graduate studies in experimental psychology (1979) and neuropsychology (1986) at the University of Montreal. His doctoral dissertation examined residual vision in the blind visual field of patients missing a cerebral hemisphere. He is a member of the Ordre des psychologues du Québec and the Société des experts en évaluation médico-légale du Québec.

His research has been funded by CIHR, NSERC, FRQS, NFB-REPAR, CASM/NHL, the Heart and Stroke Foundation, the Marie-Robert Foundation, and MITACS. In recent years, he has used functional magnetic resonance imaging (fMRI) to study post-stroke motor recovery and the neural substrates of blind vision following hemispherectomy. He has also demonstrated that this technique, along with diffusion tensor imaging and evoked potentials, can be used to explore the neural mechanisms underlying traumatic brain injury, particularly in athletes. Dr. Ptito and his research team have pointed to abnormal activation patterns following traumatic brain injury and studied how fMRI can be used as an objective method to assess the severity of an injury and the recovery that follows. In addition to his work with athletes, he is now applying the findings of his research to the general traumatic brain injury population, which includes soldiers, athletes, motor vehicle accident victims, and children.

In recent years, Dr. Ptito has been exploring new treatment modalities, namely high frequency repetitive transcranial magnetic stimulation, to help alleviate post-concussion symptoms such as depression and cognitive impairment in mild traumatic brain injury patients. He has also begun employing a new approach to treatment, tongue stimulation neuromodulation combined with intensive physical therapy, to improve gait and balance after mild to moderate head injuries.

Read more
1440 Ste Catherine Ouest, Suite 205, Montréal, QC, H3G 1R8
(514) 867-4718